Xpert® CT/NG
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
GXCT/NG-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
product image
Swab Specimen Collection Kit (Pack of 50)
SWAB/G-50
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
product image
Urine Collection Kit (Pack of 50)
URINE/A-50
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.1
CDC recommends:2
  • Annual CT/NG screening of all sexually-active women under 25 years old
  • Screening of other at-risk individuals including MSM*
  • Testing for chlamydia, gonorrhea, and trichomoniasis using NAATs^ (PCR)
  • Same-day testing and treatment
1 Gaydos C, et al. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management:Report of a Randomized Clinical Trial. Ann Emerg Med. Sept 2018.
2 St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–1916.DOI: http://dx.doi.org/10.15585/mmwr.mm6950a6
* MSM — men who have sex with men
^ NAAT — nucleic acid amplification test

The Solution

Accurate on-demand PCR results are ready when you need them
  • On-demand and in-visit results reduce patient
    call-backs, overtreatment, undertreatment and patients
    lost to follow-up
  • Patient-collected specimens can create operational
    efficiencies

The Impact

Provide fast patient results to:
  • Delivers an accurate differential diagnosis which informs appropriate treatment on time, first time, potentially improving clinical outcomes1
  • Flexible, easy to use, on-demand test designed with optimized workflow efficiencies for the fast diagnosis of chlamydia and/or gonorrhea1
  • Helps labs and clinicians to meet guidelines for diagnosis of chlamydia and gonorrhea2
1 Gaydos C, et al. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management:Report of a Randomized Clinical Trial. Ann Emerg Med. Sept 2018.
2 St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–1916.DOI: http://dx.doi.org/10.15585/mmwr.mm6950a6